Earlier studies from our laboratory demonstrated that the terpolymer of L-glutamic acid, L-alanine, and L-tyrosine (GAT) stimulated the development of T cells capable of specifically suppressing the antibody responses in vivo and in vitro of nonresponder strains (bearing the H-2 "~, H-2 q, and H-2" haplotypes) to GAT complexod with an immunogenic carrier, methylatod bovine serum albumin, MBSA (1, 2). We then extended these findings to another antigen, the copolymer of L-glutamic acid and L-tyrosine (GT). None of 19 inbred or congenic resistant mouse strains developed antibody responses to GT after immunization with this synthetic polypeptide in adjuvants. All the strains investigated, however, developed IgG plaque-forming cells (PFC) primary responses to GT complexed with MBSA (3). This permitted us to determine that: (a) preimmunization with GT suppressed the response to GT-MBSA in certain but not in all strains; (b) the suppression could be transferred by thymocytes and spleen cells from GT-primed animals; (c) the development of GT-specific suppressor cells is under dominant control of H-2-1inked gene(s) which have been designated specific immune suppressor genes (Is genes); (d) the Is genes are antigen specific since GAT-MBSA responses are suppressed by GAT in strains carrying the H-2 q haplotype, while GT-MBSA responses are not suppressed by the related polymer GT in these same strains (3, 4).
MBSA was prepared according to the method of Sueoka and Cheng (5) . The GT and GAT solutions and the complexes of these antigens with MBSA were prepared as described previously
(I, 4).
Immunization. To investigate the suppressive properties of GT for different mouse strains, mice were injected intraperitoneally initially with 100 ~g GT in a mixture of I nag magnesium and aluminum hydroxides (Maalox, William H. Rorer, Inc., Fort Washington, Pa.) or with Maalox alone. 3 days later the mice were immunized intraperitoneally with 10 ~g of GT as GT-MBSA. Since our experience demonstrated that different strains of mice required different adjuvants (complete Freund's or pertussis vaccine) for optimal PFC responses, the appropriate adjuvant was selected for each strain as indicated in the Tables. When complete Freund's adjuvant was used, the antigen was emulsified with an equal volume of complete Freund's adjuvant (Difco Laboratories, Detroit, Mich.). When pertussis vaccine was used, mice were injected with antigen in Img Maalox with 2 × 10 y killed Bordetella pertussis organisms (Eli Lilly and Co., Indianapolis, Ind.). Hemolytic Plaque Assay. The antibody response to GT-MBSA was assayed 7 days after immunization using a modification of the Jerne hemolytic plaque technique described by Pierce et al. (6) . As in previous studies the GT-MBSA response was assayed on sheep red blood cells coupled with the cross-reacting polymer GAT, GAT-SRBC (3).
Since it was noted in our previous studies that the PFC responses in the spleens to GT-MBSA are restricted to the IgG class, the plaques were developed using suitable rabbit antirnouse Ig antisera at the appropriate dilution and guinea pig complement as described (3) . GT-specific plaques were determined by subtracting the number of PFC remaining after inhibition by a suitable dilution of GAT from the number of plaques detected on GAT-SRBC in the absence of the specific inhibitor (1, 3) . All assays were done in duplicate and the number of PFC per spleen recorded.
Results and Discussion
The ability of a variety of inbred, congenic resistant, and H-2-recombinant strains to show suppressed GT-MBSA primary PFC responses as a result of preimmunization with GT is presented in Table I . The development of GTspecific suppression is controlled by genes in the H-2 complex, as reported earlier (4). Mouse strains bearing the H-2 k, H-2 ~, or H-2" haplotypes but not H-2 ~ or H-2 ~ haplotypes are specifically suppressed by GT preimmunization regardless of the genes contributed by the B10 or the A backgrounds in the congenic resistant strains.
A most intriguing finding presented in Table I is the failure of GT to suppress GT-MBSA response in the recombinant strains B10.A and A/J and 9R and B10.HTT. The B10.A and A/J strains bear natural H-2 recombinants between the two "GT suppressor" haplotypes H-2 d and H-2 k, whereas B10.HTT is a recombinant between the "GT suppressor" haplotypes H-2" and H-2 tl. In addition, the 9R strain is a recombinant comprising the left side of H-2' and the right side of H-2 a (which is thought to be identical to the right side of the "GT suppressor" H-2 d haplotype). The recombinant events in all these strains occurred between the IB and IC subregions. These observations indicate that: (a) GT-specific suppression is controlled by at least two complementing or interacting loci; (b) that there are restrictions in the ability of GT suppressor genes to complement when they come from different haplotypes (we shall refer to this phenomenon as the requirement for coupled complementation); and (c) that the genes responsible for the control of GT-specific suppression are different in H-2 d, H-2 k, and H-2" suppressor haplotypes. The patterns of responsiveness of the HTG (Table II) and 7R (Table I ) recombinant strains establish that the D locus is not concerned with GT-specific suppression. Conversely the finding that the DEBR~ ET AL.
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BRIEF DEFINITIVE REPORT NS, not significant. Vertical bar indicates location of crossing over event. *100 ~tg of GT or Maalox alone was administered intraperitoneally, followed 3 days later by 10 ~zg ofGT complexed with MBSA. 7 days later the number of specific IgG PPC per spleen were counted using GAT-coated SRBC. All strains except B10, B10.D2, B10.S, B10.A, and 7R were immunized with complete Freund's adjuvant. B10, B10.D2, B10.S, B10.A, and 7R mice were immunized using Maalox and B. pertuss/~ as adjuvant. NS, not significant. Vertical bar indicates location of crossing over event. * Immunization doses and procedures were the same as described in Table I . HTG and D2.GD swains were immunized with complete Fraund's adjuvant. B10.A and (D2.GD x B10.A)F~ were immunized with Maalox and B. pertussis as adjuvant.
A.TL strain can be suppressed in its GT-MBSA response by GT preimmunization rules out a contribution by the K locus to this phenomenon and establishes that the complementing suppressor genes map in the I and/or S regions of the H-2 complex and more probably in the I region, known to be concerned with the regulation of immune responses to thymus-dependent antigens (7) . The data presented in Table II suggest that, when genes from the same "suppressor' H-2 d haplotype capable of complementation for GT-specific suppression are found in the trans configuration as in the (D2.GD x B10.A)FI, GT-specific suppression of GT-MBSA primary PFC responses can be observed. Collectively, these various experiments may be interpreted to indicate that complementing genes in I-C and genes in I-A and/or I-B are responsible for the development of GT-specific suppression. This situation is, in several respects, analogous with the genetic control of antibody responses (8) and of in vitro stimulation of DNA synthesis (9) in animals immunized with the terpolymer of L-glutamic acid, Llysine, and L-phenylalanine (GI~) except that in the case of the GL~ Ix genes, complementation was demonstrable by the responsiveness of recombinant strains derived from strains bearing nonresponder haplotypes (8) ; in the case of GT Is genes, we are faced with the reverse situation, i.e., recombinants between strains bearing suppressor haplotypes fail to show suppression and yet cannot be demonstrated to behave as unequivocal GT responder strains (3) . The data imply, therefore, a very close if not, as yet, an absolute reverse relationship between the control of specific responsiveness and specific suppression by complementing l-region genes. The close relationship between Ix and Is genes is also supported by the observations that (a) weak but definite T-cell helper activity has been reported ih GAT nonresponder strains under appropriate experimental conditions (10); and (b) the development of transient PFC responses to GT in nonresponder H-2 d BALB/c mice treated with an appropriate dose of cyclophosphamide known to destroy suppressor T-cell activity (11) . The ability of preimmunization with GAT or GT to suppress the response of genetic nonresponder strains to GAT-MBSA or GT-MBSA, respectively, can be transferred by antigen-specific factors obtained from thymocytes or spleen cells from animals primed with the copolymers (12, and footnote 1). The complementary genes concerned with the control of GT-specific suppression could control the synthesis and/or release of the suppressor factor or its ability to exert its regulatory activity on cells of the immune system. Studies in progress to explore these possibilities suggest strain restrictions in the ability of GAT-specific and GT-specific suppressor factors to exert their effects in recipient animals (12, and footnote 1).
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